secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001493152-26-008037
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Mary Fisher resigns from Dermata board, effective March 31, 2026
-------------------------------------------------------------------------

- Resignation due to her employer being acquired; no longer permitted to serve on board.
- No disagreement with company or management cited.
- Board size to decrease from eight to seven after resignation effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226008037/0001493152-26-008037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226008037/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer